ICSA 2025: Bridging Science and Innovation in Cellular Senescence


The Phaedon Institute is honored to co-host the 2nd Seno-Therapeutics Summit together with the 10th Annual International Cell Senescence Association (ICSA) Conference, held from September 16–19 at the National Research Council (CNR) in Rome, Italy.

This landmark gathering brings together the world’s leading scientists, innovators, and industry pioneers in senescence biology to explore cutting-edge therapeutic strategies for aging and age-related diseases. Among the distinguished participants is Maria Mittelbrunn, whose pioneering research on immune aging and senescence adds a vital perspective to the summit’s mission of advancing translational science.

Through collaboration across academia, biotechnology, and regulatory fields, the Seno-Therapeutics Summit and ICSA Conference aim to drive innovation and set new standards for research that improves human health and longevity.

Compartir en X
Compartir en Linkedin

Related News

Mittelbrunn Lab will relocate to CaixaResearch Institute

María Mittelbrunn joins CaixaResearch Institute to advance healthy aging research.

CaixaResearch Institute Inaguration: A New Era for Immunology Research in Spain

CaixaResearch Institute opens, uniting top scientists to advance immune therapies.